Article Details
Retrieved on: 2022-05-26 15:36:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Tyme Technologies is a clinical-stage biopharma company trading at a large discount to net cash + marketable securities. Read the outlook for TYME ...
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here